Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population

Table 2

IV visit costs per patient per visit (PPPV) and per patient per month (PPPM) by cost categories.

No. of visits
PPPV	13,583
PPPM	6,025
			Costs PPPV ($)^1					Costs PPPM ($)^1
Cost category	Sum ($)^2	%	Median	Mean	Std. dev.	1st quartile	3rd quartile	Median	Mean	Std. dev.	1st quartile	3rd quartile
Total	32,970,401	100.0%	1,532.11	2,427.33	2,674.95	720.50	3,187.80	4,310.20	5,467.61	133.01	2,065.64	7,430.99
IV administration	5,425,305	16.5%	342.01	399.42	291.78	226.62	513.84	678.54	899.57	24.91	395.94	1,130.75
Chemotherapy administration	4,044,094	74.5%	253.53	297.73	227.91	163.67	379.00	489.72	670.50	19.34	282.65	832.90
Hydration administration	75,244	1.4%	0.00	5.54	23.55	0.00	0.00	0.00	12.45	1.26	0.00	2.55
Therapeutic, diagnostic, prophylactic admin.	1,305,967	24.1%	77.40	96.15	100.63	31.94	130.82	156.15	216.61	7.12	72.72	276.57
IV drug (for mSTS)	19,693,317	59.7%	537.77	1,449.85	2,175.31	98.59	1,828.55	2,236.07	3,268.45	102.50	427.21	4,703.56
Other visit-related services	7,851,778	23.8%	190.55	578.06	1,178.00	42.31	483.00	725.44	1,299.60	51.60	294.02	1,573.49
Miscellaneous administration	112,606	1.4%	0.00	8.29	72.83	0.00	0.00	0.00	18.68	1.52	0.00	15.69
Supplies/equipment	14,537	0.2%	0.00	1.07	13.76	0.00	0.00	0.00	2.39	0.57	0.00	0.00
Office visit/evaluation and mgmt. services	168,391	2.1%	0.00	12.40	41.77	0.00	0.00	0.00	27.90	2.00	0.00	4.18
Other IV drugs/specially admin. oral drugs	7,556,244	96.2%	185.76	556.30	1,167.77	17.25	468.02	688.65	1,250.63	51.33	241.48	1,498.94
Antihypercalcemic agents	407,395	5.4%	0.00	29.99	260.40	0.00	0.00	0.00	67.62	7.25	0.00	0.00
Colony-stimulating factor	2,175,927	28.8%	0.00	160.19	699.58	0.00	0.00	0.00	358.66	27.14	0.00	58.14
Antiemetic	2,317,729	30.7%	95.85	170.63	220.46	0.71	254.66	291.67	384.22	11.32	54.81	556.62
Use for IV infusion	90,036	1.2%	0.00	6.63	15.56	0.00	2.72	0.21	14.94	1.25	0.00	5.39
Corticosteroid for hypersensitivity	53,693	0.7%	1.09	3.95	16.74	0.00	2.33	2.67	8.91	0.91	0.98	6.32
Used to clear (flush) IV lines or catheters	6,515	0.1%	0.00	0.48	5.49	0.00	0.00	0.00	1.08	0.39	0.00	0.00
H2 antagonists for hypersensitivity	3,533	0.0%	0.00	0.26	2.54	0.00	0.00	0.00	0.59	0.08	0.00	0.00
For anemia	4,987	0.1%	0.00	0.37	7.79	0.00	0.00	0.00	0.83	0.23	0.00	0.00
Anticancer agent monoclonal antibody	1,143,295	15.1%	0.00	84.17	713.08	0.00	0.00	0.00	189.76	32.30	0.00	0.00
Anticancer agent chemotherapy	674,420	8.9%	0.00	49.65	319.96	0.00	0.00	0.00	111.43	21.30	0.00	0.00
Misc. other drugs	678,714	9.0%	0.00	49.97	358.51	0.00	1.34	1.93	112.59	10.55	0.00	26.98

1: Treatment costs derived from the contracted allowed payment for a claim.
2: Sum over all visits/months and patients.